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Aims and objectives: In Lebanon, the trend of tuberculosis (TB) incidence had been declining
until the year 2011. In 2012, the National TB Program (NTP) observed that 48% of all notified
cases were among the Syrian refugee population. As of August 2013, according to the NTP,
100 Syrian refugees have been diagnosed with TB in Lebanon, including 3 cases of MDR
(multidrug-resistant) TB.
Resistance-associated point mutations have already been described for commonly used
anti-TB drugs. The widespread use of Isoniazid (INH), a cornerstone drug for treating TB,
has seen treatment failures due to increasing resistance to the drug. Clinical resistance
to INH is widely known to be caused by mutations within katG, inhA and ahpC genes. The
objective of this study is to determine by pyrosequencing the prevalence of mutations on
the codon 315 of the katG gene, on the inhA promoter and on the ahpC-oxyR intergenic
region in 14 and 52 INH-resistant MTB isolates recovered from TB patients in Lebanon
and Syria, respectively.
Methods: The clinical isolates were provided by the Medical Biotechnology Section of the
National Commission for Biotechnology in Syria and the Health and Environment
Microbiology Laboratory at the Azm Center for Research in Biotechnology at the Lebanese
University. The isolates were derived from 52 Syrian and 14 Lebanese patients between July
2003 and October 2005 from all Syrian and Lebanese provinces. The identification of point
mutations on katG, inhA and ahpC-oxyR intergenic region was performed by pyrosequenc-
ing, and sequences from clinical isolates were compared with that of wild-type MTB ATCC
25177.
Results: The results showed that among the 52 Syrian isolates, 22 (42.3%) had the aa 315
mutation in the katG gene, while 6 of the 14 Lebanese strains (42.8%) had this mutation.
The most common mutation was Ser315Thr (92.8%). Mutations in the inhA promoter region
were responsible for INH resistance in 14 Syrian strains (26.9%) of the isolates. The most
common inhA promoter mutation was 15 C-T and was present in 13 of the14 inhA muta-
tions. Screening for mutations on the ahpC-oxyR intergenic region revealed the presence of, Doctoral
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is interesting to note that 4 strains had mutations in katG in addition to ahpC-oxyR
mutations and 1 strain had both katG and inhA mutations.
None of the Lebanese strains had mutations on inhA or ahpC-oxyR implying that these
mutations do not contribute to the detection of INH-resistant MTB in the Lebanese strains.
Conclusions: This study showed that the pyrosequencing applied to katG, inhA promoter and
ahpC-oxyR intergenic region was able to detect a relatively large proportion of Syrian INH-
resistant MTB isolates (80.7%) in Syria. This strategy may be inappropriate for Lebanese
strains, as the genetic mechanisms of resistance remain unidentified for approximately
half of the isolates, so it is quite possible to detect the presence of other mechanisms of
resistance.
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